Indication
Hepatobiliary Cancer
2 clinical trials
3 products
Clinical trial
Phase II Basket Trial of Domvanalimab (AB154) and Zimberelimab (AB122) in Advanced Hepatobiliary CancersStatus: Recruiting, Estimated PCD: 2026-07-01
Product
ZimberelimabProduct
DomvanalimabClinical trial
Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)Status: Active (not recruiting), Estimated PCD: 2022-03-06